Emergent BioSolutions Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
4 Biotech Stocks To Watch In The New Year
Article By: Zacks Investment Research
Sunday, January 7, 2018 5:23 PM EDT
Biotech companies are continuously working on bringing innovative new treatments to market, and there could be significant catalysts in the coming quarters in the form of important product approvals as well as major data read-outs.
In this article: EBS, GSK, MDCO, XOMA, EXEL, NVS, MLNT
Read
Emergent BioSolutions Get Approval For New Construction Site In Germany
Article By: KKD Healthcare Analytics
Monday, January 30, 2017 12:50 PM EDT
Emergent BioSolutions announced receiving approval from German Federal Ministry of Health for the construction of Building 55. The building will be used for manufacturing BioThrax.
In this article: EBS
Read
GlaxoSmithKline Q1 Earnings Lag, Revenues Up Y/Y
Article By: Zacks Investment Research
Thursday, April 28, 2016 8:30 PM EDT
GlaxoSmithKline PLC reported first-quarter 2016 core earnings of 57 cents per American Depositary Share (ADS), missing the Zacks Consensus Estimate of 60 cents. Nevertheless, the company’s shares inched up 1.8% following the news.
In this article: EBS, GSK, NVS, ANIK
Read
Top 5 Stocks With Increasing Cash Flows
Article By: Zacks Investment Research
Tuesday, April 26, 2016 4:39 AM EDT
While in the heart of the first-quarter earnings season, investors might find it easy to look for profits and surprises to scoop up big gains.
In this article: EBS, FOR, JBT, ANIK, NSAT
Read
3 Cheap Tech Stocks With Massive Growth Potential
Article By: Zacks Investment Research
Wednesday, March 23, 2016 8:17 AM EDT
Finding companies with the criteria you want isn’t always easy. You could spend hours searching ticker after ticker, only to find companies which aren’t worthy of your hard earned cash.
In this article: MXL, EBS, ORBK
Read

PARTNER HEADLINES

Latest Tweets for $EBS

No tweets yet!